MARKET

SENS

SENS

SENSEONICS
AMEX

Real-time Quotes | Nasdaq Last Sale

1.828
+0.028
+1.57%
Opening 13:27 05/11 EDT
OPEN
1.690
PREV CLOSE
1.800
HIGH
1.850
LOW
1.620
VOLUME
11.45M
TURNOVER
--
52 WEEK HIGH
5.56
52 WEEK LOW
0.3497
MARKET CAP
782.31M
P/E (TTM)
-2.4464
1D
5D
1M
3M
1Y
5Y
Global Continuous Glucose Monitoring Systems Market Size, Share and Growth to Accrue USD 5280 million By 2025
Market Insight Reports · 1d ago
Global Continuous Glucose Monitoring Market Size, Share, Value, and Competitive Landscape 2024
May 09, 2021 (Heraldkeepers) -- A continuous glucose monitoring (CGM) tracks glucose levels throughout the day and night and can alert you if your levels go...
Heraldkeepers · 2d ago
Will Senseonics Holdings (SENS) Report Negative Earnings Next Week? What You Should Know
Zacks.com · 4d ago
Continuous Glucose Monitoring Systems Market Size, Share 2021 By Regional Analysis, Growing At A CAGR of 20.6%, Top Key Leaders, Investment Opportunities, Gross margin, Segmentation and Industry Growth, Development Status, Outlook till 2026
May 04, 2021 (The Expresswire) -- The global “Continuous Glucose Monitoring Systems Market” research report focuses on the confined major statistical...
The Express Wire · 05/04 06:03
Biosensors Market with COVID-19 Impact by Type, Product, Technology, Application and Region - Global Forecast to 2026
Dublin, April 30, Apr 30, 2021 (GLOBE NEWSWIRE via COMTEX) -- Dublin, April 30, 2021 (GLOBE NEWSWIRE) -- The "Biosensors Market with COVID-19 Impact by Type,...
GlobeNewswire · 04/30 09:19
Senseonics Holdings, Inc. Schedules First Quarter 2021 Earnings Release and Conference Call for May 13, 2021 at 4:30 p.m. Eastern Time
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to ...
Business Wire · 04/29 20:14
Continuous Glucose Monitoring Devices Market Development Status, Emerging Technologies, Regional Trends and Comprehensive Research Study 2025
Apr 28, 2021 (AmericaNewsHour) -- A comprehensive research report created through extensive primary research (inputs from industry experts, companies,...
AmericaNewsHour · 04/28 07:39
Continuous Glucose Monitoring Sales Market 2021 Size, Share and Outlook 2025: COVID-19 Market Scenario, Business Strategies, Growth Factors, Opportunity, Sales Revenue, Emerging Demands, Regional Analysis by Industry Research Biz
Apr 28, 2021 (The Expresswire) -- Global “Continuous Glucose Monitoring Sales Market” 2021 research report represents a detailed overview of the current...
The Express Wire · 04/28 04:16
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SENS. Analyze the recent business situations of SENSEONICS through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SENS stock price target is 2.300 with a high estimate of 4.000 and a low estimate of 0.7000.
EPS
Institutional Holdings
Institutions: 117
Institutional Holdings: 93.52M
% Owned: 21.85%
Shares Outstanding: 427.91M
TypeInstitutionsShares
Increased
49
4.74M
New
13
3.28M
Decreased
18
5.37M
Sold Out
21
1.58M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.30%
Pharmaceuticals & Medical Research
-0.30%
Key Executives
Chairman/Independent Director
Stephen DeFalco
President/Chief Executive Officer/Director
Timothy Goodnow
Chief Financial Officer/Treasurer/Secretary
Nick Tressler
Chief Operating Officer
Mukul Jain
Vice President/General Manager
Mirasol Panlilio
Other/Director
Francine Kaufman
Director
Anthony Raab
Director
Robert Schumm
Independent Director
Steven Edelman
Independent Director
Edward Fiorentino
Independent Director
Peter Klein
Independent Director
Douglas Prince
Independent Director
Douglas Roeder
No Data
About SENS
Senseonics Holdings, Inc. is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes. The Company's Eversense system consists of components, such as a sensor, which is inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user's mobile device, such as a smartphone, Apple Watch or tablet.

Webull offers kinds of Senseonics Holdings Inc stock information, including AMEX:SENS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SENS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SENS stock methods without spending real money on the virtual paper trading platform.